PSMA-PET/CT findings were positive in 84% of the patients. PSMA-PET/CT detected distant metastatic disease in 46% of patients, including 34% of patients after RP, 56% after definitive RT, and 60% ...

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

Separate studies investigated the potential role of multiparametric MRI in refining prostate cancer active surveillance practices, such as confirmatory biopsy.

A breakthrough experimental drug has shown promising results in shrinking advanced prostate cancer tumours, offering new hope ...